help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Saito, T.
Right arrow Articles by Onaya, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saito, T.
Right arrow Articles by Onaya, T.
The Journal of Clinical Endocrinology & Metabolism Vol. 82, No. 10 3331-3336
Copyright © 1997 by The Endocrine Society


Original Studies

Increased Expression of the Na+/I- Symporter in Cultured Human Thyroid Cells Exposed to Thyrotropin and in Graves’ Thyroid Tissue1

Tsukasa Saito, Toyoshi Endo, Akio Kawaguchi, Masato Ikeda, Minoru Nakazato, Takahiko Kogai and Toshimasa Onaya

Third Department of Internal Medicine, Yamanashi Medical University, Tamaho, Yamanashi 409–38, Japan

Address all correspondence and requests for reprints to: T. Onaya, M.D., Ph.D., Third Department of Internal Medicine, Yamanashi Medical University, Tamaho, Yamanashi 409–38, Japan.

The Na+/I- symporter (NIS) is important in hormone synthesis in the thyroid gland. NIS activity, as reflected by I- uptake, was increased by TSH (1 mU/mL) or forskolin (10 µmol/L) in primary cultured human thyroid cells. Northern blot analysis revealed that incubation of these cells with TSH or forskolin for 24 h increased the abundance of NIS messenger ribonucleic acid (mRNA) 2.3- and 2.5-fold, respectively. Immunoblot analysis revealed 2.7- and 2.4-fold increases, respectively, in the amount of NIS protein after 48 h, suggesting that elevated levels of intracellular cAMP induced the expression of NIS in human thyrocytes. We then studied the levels of NIS mRNA and protein in Graves’ thyroid tissue and found that the amount of NIS mRNA in thyroid tissue from individuals with Graves’ disease (n = 5) was 3.8 times that in normal thyroid tissue (n = 5). The abundance of NIS mRNA was significantly correlated with that of thyroid peroxidase or thyroglobulin mRNAs, but not with that of TSH receptor mRNA, in the Graves’ and normal thyroid tissue specimens. The amount of NIS protein was also increased 3.1-fold in Graves’ thyroid tissue compared with that in normal thyroid tissue. The increased expression of NIS may thus contribute to the development of Graves’ disease.




This article has been cited by other articles:


Home page
EndocrinologyHome page
M. S. Fenton, K. M. Marion, and J. M. Hershman
Identification of Cyclic Adenosine 3',5'-Monophosphate Response Element Modulator as an Activator of the Human Sodium/Iodide Symporter Upstream Enhancer
Endocrinology, May 1, 2008; 149(5): 2592 - 2606.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. M. Norden, F. Larsson, S. Tedelind, T. Carlsson, C. Lundh, E. Forssell-Aronsson, and M. Nilsson
Down-regulation of the Sodium/Iodide Symporter Explains 131I-Induced Thyroid Stunning
Cancer Res., August 1, 2007; 67(15): 7512 - 7517.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
D. D Vadysirisack, A. Venkateswaran, Z. Zhang, and S. M Jhiang
MEK signaling modulates sodium iodide symporter at multiple levels and in a paradoxical manner
Endocr. Relat. Cancer, June 1, 2007; 14(2): 421 - 432.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
T Kogai, K Taki, and G A Brent
Enhancement of sodium/iodide symporter expression in thyroid and breast cancer.
Endocr. Relat. Cancer, September 1, 2006; 13(3): 797 - 826.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
R. Opitz, A. Trubiroha, C. Lorenz, I. Lutz, S. Hartmann, T. Blank, T. Braunbeck, and W. Kloas
Expression of sodium-iodide symporter mRNA in the thyroid gland of Xenopus laevis tadpoles: developmental expression, effects of antithyroidal compounds, and regulation by TSH.
J. Endocrinol., July 1, 2006; 190(1): 157 - 170.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
F. Bernier-Valentin, S. Trouttet-Masson, R. Rabilloud, S. Selmi-Ruby, and B. Rousset
Three-Dimensional Organization of Thyroid Cells into Follicle Structures Is a Pivotal Factor in the Control of Sodium/Iodide Symporter Expression
Endocrinology, April 1, 2006; 147(4): 2035 - 2042.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. Bruno, E. Ferretti, E. Tosi, F. Arturi, P. Giannasio, T. Mattei, A. Scipioni, I. Presta, R. Morisi, A. Gulino, et al.
Modulation of Thyroid-Specific Gene Expression in Normal and Nodular Human Thyroid Tissues from Adults: An in Vivo Effect of Thyrotropin
J. Clin. Endocrinol. Metab., October 1, 2005; 90(10): 5692 - 5697.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
N. Caraccio, R. Giannini, S. Cuccato, P. Faviana, P. Berti, D. Galleri, A. Dardano, F. Basolo, E. Ferrannini, and F. Monzani
Type I Interferons Modulate the Expression of Thyroid Peroxidase, Sodium/Iodide Symporter, and Thyroglobulin Genes in Primary Human Thyrocyte Cultures
J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 1156 - 1162.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
F. Furuya, H. Shimura, A. Miyazaki, K. Taki, K. Ohta, K. Haraguchi, T. Onaya, T. Endo, and T. Kobayashi
Adenovirus-Mediated Transfer of Thyroid Transcription Factor-1 Induces Radioiodide Organification and Retention in Thyroid Cancer Cells
Endocrinology, November 1, 2004; 145(11): 5397 - 5405.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M. Dentice, C. Luongo, A. Elefante, R. Romino, R. Ambrosio, M. Vitale, G. Rossi, G. Fenzi, and D. Salvatore
Transcription Factor Nkx-2.5 Induces Sodium/Iodide Symporter Gene Expression and Participates in Retinoic Acid- and Lactation-Induced Transcription in Mammary Cells
Mol. Cell. Biol., September 15, 2004; 24(18): 7863 - 7877.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. De Felice, M. P. Postiglione, and R. Di Lauro
Minireview: Thyrotropin Receptor Signaling in Development and Differentiation of the Thyroid Gland: Insights from Mouse Models and Human Diseases
Endocrinology, September 1, 2004; 145(9): 4062 - 4067.
[Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. Trouttet-Masson, S. Selmi-Ruby, F. Bernier-Valentin, V. Porra, N. Berger-Dutrieux, M. Decaussin, J.-L. Peix, A. Perrin, C. Bournaud, J. Orgiazzi, et al.
Evidence for Transcriptional and Posttranscriptional Alterations of the Sodium/Iodide Symporter Expression in Hypofunctioning Benign and Malignant Thyroid Tumors
Am. J. Pathol., July 1, 2004; 165(1): 25 - 34.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
F. Furuya, H. Shimura, H. Suzuki, K. Taki, K. Ohta, K. Haraguchi, T. Onaya, T. Endo, and T. Kobayashi
Histone Deacetylase Inhibitors Restore Radioiodide Uptake and Retention in Poorly Differentiated and Anaplastic Thyroid Cancer Cells by Expression of the Sodium/Iodide Symporter Thyroperoxidase and Thyroglobulin
Endocrinology, June 1, 2004; 145(6): 2865 - 2875.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Kogai, Y. Kanamoto, L. H. Che, K. Taki, F. Moatamed, J. J. Schultz, and G. A. Brent
Systemic Retinoic Acid Treatment Induces Sodium/Iodide Symporter Expression and Radioiodide Uptake in Mouse Breast Cancer Models
Cancer Res., January 1, 2004; 64(1): 415 - 422.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
O. Dohan, A. De la Vieja, V. Paroder, C. Riedel, M. Artani, M. Reed, C. S. Ginter, and N. Carrasco
The Sodium/Iodide Symporter (NIS): Characterization, Regulation, and Medical Significance
Endocr. Rev., February 1, 2003; 24(1): 48 - 77.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
T. Kondo, N. Nakamura, K. Suzuki, S.-i. Murata, A. Muramatsu, A. Kawaoi, and R. Katoh
Expression of Human Pendrin in Diseased Thyroids
J. Histochem. Cytochem., February 1, 2003; 51(2): 167 - 173.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
K. Taki, T. Kogai, Y. Kanamoto, J. M. Hershman, and G. A. Brent
A Thyroid-Specific Far-Upstream Enhancer in the Human Sodium/Iodide Symporter Gene Requires Pax-8 Binding and Cyclic Adenosine 3',5'-Monophosphate Response Element-Like Sequence Binding Proteins for Full Activity and Is Differentially Regulated in Normal and Thyroid Cancer Cells
Mol. Endocrinol., October 1, 2002; 16(10): 2266 - 2282.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. R. Castro, E. R. Bergert, J. R. Goellner, I. D. Hay, and J. C. Morris
Immunohistochemical Analysis of Sodium Iodide Symporter Expression in Metastatic Differentiated Thyroid Cancer: Correlation with Radioiodine Uptake
J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5627 - 5632.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. P. Schroder-van der Elst, D. van der Heide, J. Kastelijn, B. Rousset, and M. Jesus Obregon
The Expression of the Sodium/Iodide Symporter Is Up-Regulated in the Thyroid of Fetuses of Iodine-Deficient Rats
Endocrinology, September 1, 2001; 142(9): 3736 - 3741.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. Kogai, J. M. Hershman, K. Motomura, T. Endo, T. Onaya, and G. A. Brent
Differential Regulation of the Human Sodium/Iodide Symporter Gene Promoter in Papillary Thyroid Carcinoma Cell Lines and Normal Thyroid Cells
Endocrinology, August 1, 2001; 142(8): 3369 - 3379.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Spitzweg, K. J. Harrington, L. A. Pinke, R. G. Vile, and J. C. Morris
The Sodium Iodide Symporter and Its Potential Role in Cancer Therapy
J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 3327 - 3335.
[Full Text] [PDF]


Home page
Cancer Res.Home page
C. Spitzweg, M. K. O’Connor, E. R. Bergert, D. J. Tindall, C. Y. F. Young, and J. C. Morris
Treatment of Prostate Cancer by Radioiodine Therapy after Tissue-specific Expression of the Sodium Iodide Symporter
Cancer Res., November 1, 2000; 60(22): 6526 - 6530.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
D. Cauvi, C. Penel, M. C. Nlend, N. Venot, C. Allasia, and O. Chabaud
Regulation of thyroid cell volumes and fluid transport: opposite effects of TSH and iodide on cultured cells
Am J Physiol Endocrinol Metab, September 1, 2000; 279(3): E546 - E553.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Spitzweg, W. Joba, K. Schriever, J. R. Goellner, J. C. Morris, and A. E. Heufelder
Analysis of Human Sodium Iodide Symporter Immunoreactivity in Human Exocrine Glands
J. Clin. Endocrinol. Metab., November 1, 1999; 84(11): 4178 - 4184.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
V. Lazar, J.-M. Bidart, B. Caillou, C. Mahé, L. Lacroix, S. Filetti, and M. Schlumberger
Expression of the Na+/I- Symporter Gene in Human Thyroid Tumors: A Comparison Study with Other Thyroid-Specific Genes
J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3228 - 3234.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
P. H. K. Eng, G. R. Cardona, S.-L. Fang, M. Previti, S. Alex, N. Carrasco, W. W. Chin, and L. E. Braverman
Escape from the Acute Wolff-Chaikoff Effect Is Associated with a Decrease in Thyroid Sodium/Iodide Symporter Messenger Ribonucleic Acid and Protein
Endocrinology, August 1, 1999; 140(8): 3404 - 3410.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
B. Caillou, F. Troalen, E. Baudin, M. Talbot, S. Filetti, M. Schlumberger, and J.-M. Bidart
Na+/I- Symporter Distribution in Human Thyroid Tissues: An Immunohistochemical Study
J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 4102 - 4106.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
K.-Y. Ryu, Q. Tong, and S. M. Jhiang
Promoter Characterization of the Human Na+/I- Symporter
J. Clin. Endocrinol. Metab., September 1, 1998; 83(9): 3247 - 3251.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
C. Riedel, O. Levy, and N. Carrasco
Post-transcriptional Regulation of the Sodium/Iodide Symporter by Thyrotropin
J. Biol. Chem., June 8, 2001; 276(24): 21458 - 21463.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. Kogai, J. J. Schultz, L. S. Johnson, M. Huang, and G. A. Brent
Retinoic acid induces sodium/iodide symporter gene expression and radioiodide uptake in the MCF-7 breast cancer cell line
PNAS, July 18, 2000; 97(15): 8519 - 8524.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1997 by The Endocrine Society